Benjamin Haynor
Stock Analyst at Lake Street
(1.33)
# 3,600
Out of 5,005 analysts
12
Total ratings
45.45%
Success rate
-0.61%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INFU InfuSystem Holdings | Assumes: Buy | $15 | $10.36 | +44.79% | 1 | Sep 22, 2025 | |
| ELMD Electromed | Assumes: Buy | $36 | $25.07 | +43.60% | 1 | Aug 27, 2025 | |
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $5.68 | +93.83% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $32.06 | -40.74% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $8.44 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $16.35 | +8,462.69% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $29.12 | +49.38% | 1 | Jun 27, 2017 |
InfuSystem Holdings
Sep 22, 2025
Assumes: Buy
Price Target: $15
Current: $10.36
Upside: +44.79%
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $25.07
Upside: +43.60%
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $5.68
Upside: +93.83%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $32.06
Upside: -40.74%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $8.44
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $16.35
Upside: +8,462.69%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $29.12
Upside: +49.38%